reboxetine has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (guanosine 5'-o-(3-thiotriphosphate)) | Trials (guanosine 5'-o-(3-thiotriphosphate)) | Recent Studies (post-2010) (guanosine 5'-o-(3-thiotriphosphate)) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 5,542 | 8 | 368 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K; Kobayashi, T; Washiyama, K | 1 |
1 other study(ies) available for reboxetine and guanosine 5'-o-(3-thiotriphosphate)
| Article | Year |
|---|---|
Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Biophysics; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Ethanol; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Guanosine 5'-O-(3-Thiotriphosphate); Membrane Potentials; Microinjections; Morpholines; Oocytes; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Propylamines; Reboxetine; Receptor, Adenosine A1; Xenopus laevis | 2010 |